Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
6.91
-0.38 (-5.21%)
At close: Oct 8, 2025, 4:00 PM EDT
7.28
+0.37 (5.35%)
After-hours: Oct 8, 2025, 7:18 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $768.81 million as of October 8, 2025. Its market cap has decreased by -6.69% in one year.
Market Cap
768.81M
Enterprise Value
623.03M
1-Year Change
-6.69%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $768.81M, an increase of 391.86%. That is a compound annual growth rate of 42.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 768.81M | 131.62% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |